Skip to main content
Erschienen in: Journal of Public Health 5/2005

01.10.2005 | Original Article

Policy decision making and outcomes research in drug utilization

verfasst von: R. Rychlik, A. Wertheimer, H. Rusche, M. Augustin, S. Nelles, W. Böcking

Erschienen in: Journal of Public Health | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Health-care systems all over the world tend to be under permanent review and policy decision making is increasingly driven only by political decisions concerning resource allocation. Drug utilization is a major concern within policy decision making, of relevance to and sometimes even bridging both the pharmaceutical industry and medical community. Outcomes and effectiveness research emphasizes the accountability of the health-care delivery system and focuses on the medium and long-term results of treatment and preventive interventions. With increasing health-care costs and growing concerns about the quality of care, appropriate health outcome measures are essential for assessing the quality, necessity, and effectiveness of health care. These outcome measures are reviewed addressing the influence of evidenced-based medicine and discussing the underlying methods which are applied throughout Europe and the US for reimbursement purposes and application procedures in drug utilization management.
Literatur
Zurück zum Zitat Abel U, Koch A (1997) The mythology of randomization. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf Abel U, Koch A (1997) The mythology of randomization. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf
Zurück zum Zitat Breyer F, Zweifel P (1997) Gesundheitsökonomie, 2nd edn. Springer, Berlin Heidelberg New York, p 29 Breyer F, Zweifel P (1997) Gesundheitsökonomie, 2nd edn. Springer, Berlin Heidelberg New York, p 29
Zurück zum Zitat Camann MA (2001) Outcomes of care: the use of conceptual models to “see the forest and the trees” in planning outcomes studies. Top Health Inf Manage 22(2):10–14PubMed Camann MA (2001) Outcomes of care: the use of conceptual models to “see the forest and the trees” in planning outcomes studies. Top Health Inf Manage 22(2):10–14PubMed
Zurück zum Zitat CDER/CBER (Center for Drug Evaluation and Research/Center for Biological Evaluation and Research) (2004) Guidance documents. http://www.fda.gov/cder/guidance/index.htm CDER/CBER (Center for Drug Evaluation and Research/Center for Biological Evaluation and Research) (2004) Guidance documents. http://​www.​fda.​gov/​cder/​guidance/​index.​htm
Zurück zum Zitat Dannehl K (1997) Experimental study versus non-experimental study: the non-experimental (non-randomized) study as a methodological compromise. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf Dannehl K (1997) Experimental study versus non-experimental study: the non-experimental (non-randomized) study as a methodological compromise. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf
Zurück zum Zitat Healey A, Mirandola M, Amaddeo F, Bonizzato P, Tansella M (2000) Using health production functions to evaluate treatment effectiveness: an application to a community mental health service. Health Econ 9(5):373–383CrossRefPubMed Healey A, Mirandola M, Amaddeo F, Bonizzato P, Tansella M (2000) Using health production functions to evaluate treatment effectiveness: an application to a community mental health service. Health Econ 9(5):373–383CrossRefPubMed
Zurück zum Zitat Hoppe JD (2005) Qualitätswettbewerb, Nutzenbewertung und Patientenbeteiligung. Garanten für die Zukunft des GKV-Systems oder Wegbereiter für eine Zweiklassen-Medizin? Gesundh Ökon Qual Manag 10(1) (in print) Hoppe JD (2005) Qualitätswettbewerb, Nutzenbewertung und Patientenbeteiligung. Garanten für die Zukunft des GKV-Systems oder Wegbereiter für eine Zweiklassen-Medizin? Gesundh Ökon Qual Manag 10(1) (in print)
Zurück zum Zitat King JT Jr, Ratcheson RA (1998) Cost and outcomes analysis. Neurosurg Clin N Am 9(3):629–640PubMed King JT Jr, Ratcheson RA (1998) Cost and outcomes analysis. Neurosurg Clin N Am 9(3):629–640PubMed
Zurück zum Zitat Lee SJ, Earle CC, Weeks JC (2000) Outcomes research in oncology: history, conceptual framework, and trends in the literature. J Natl Cancer Inst 92(3):195–204 Lee SJ, Earle CC, Weeks JC (2000) Outcomes research in oncology: history, conceptual framework, and trends in the literature. J Natl Cancer Inst 92(3):195–204
Zurück zum Zitat Lorenz W, Koller M (2002) Empirically-based concepts of outcome and quality of life. In: Gimmler A, Lenk C, Aumüller G (eds) Health and quality of life. Philosophical, medical, and cultural aspects, 2nd edn. LIT Verlag, Münster, pp 123–136 Lorenz W, Koller M (2002) Empirically-based concepts of outcome and quality of life. In: Gimmler A, Lenk C, Aumüller G (eds) Health and quality of life. Philosophical, medical, and cultural aspects, 2nd edn. LIT Verlag, Münster, pp 123–136
Zurück zum Zitat Michaelis J (1997) Reference-controlled observational studies—a new tool for post marketing studies and for evaluation of preventive measures. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf Michaelis J (1997) Reference-controlled observational studies—a new tool for post marketing studies and for evaluation of preventive measures. In: Abel U, Koch A (eds) Nonrandomized comparative clinical studies. Proceedings of the International Conference on Nonrandomized Comparative Clinical Studies, 10–11 April 1997, Heidelberg, Germany. Symposion Publishing, Düsseldorf
Zurück zum Zitat National Institute for Clinical Excellence (2004) Guide to the methods of technology appraisal (reference N0515). http://www.nice.org.uk/pdf/TAP_Methods.pdf National Institute for Clinical Excellence (2004) Guide to the methods of technology appraisal (reference N0515). http://​www.​nice.​org.​uk/​pdf/​TAP_​Methods.​pdf
Zurück zum Zitat National Multiple Sclerosis Society (2005) Tysabri Suspended From The Market. Bulletin 03-31–2005: http://www.nationalmssociety.org/Research-2005Feb28.asp National Multiple Sclerosis Society (2005) Tysabri Suspended From The Market. Bulletin 03-31–2005: http://​www.​nationalmssociet​y.​org/​Research-2005Feb28.​asp
Zurück zum Zitat Orlewska E, Mierzejewki P (2000) Polish guidelines for conducting pharmacoeconomic evaluations. Farmakoekonomika Suppl 1:3–11 Orlewska E, Mierzejewki P (2000) Polish guidelines for conducting pharmacoeconomic evaluations. Farmakoekonomika Suppl 1:3–11
Zurück zum Zitat Prendergast ML, Podus D (2000) Drug treatment effectiveness: an examination of conceptual and policy issues. Subst Use Misuse 35(12-14):1629–1657 Prendergast ML, Podus D (2000) Drug treatment effectiveness: an examination of conceptual and policy issues. Subst Use Misuse 35(12-14):1629–1657
Zurück zum Zitat Roberts TG, Chabner BA (2004) Beyond fast track for drug approvals. New Engl J Med 351(5):501–505CrossRefPubMed Roberts TG, Chabner BA (2004) Beyond fast track for drug approvals. New Engl J Med 351(5):501–505CrossRefPubMed
Zurück zum Zitat Rychlik R (2004) Health economical evaluation of drug utilization—an international review. Gesundh Ökon Qual Manag 9(3):177–185 Rychlik R (2004) Health economical evaluation of drug utilization—an international review. Gesundh Ökon Qual Manag 9(3):177–185
Zurück zum Zitat Rychlik R, Rusche H, Augustin M (2004) Systematics of drug benefit evaluation. Gesundh Ökon Qual Manag 9(4):245–252 Rychlik R, Rusche H, Augustin M (2004) Systematics of drug benefit evaluation. Gesundh Ökon Qual Manag 9(4):245–252
Zurück zum Zitat Schmacke N (2004) Bewertung des Nutzens von Arzneimitteln aus ärztlicher Sicht. Gesundheits- und Sozialpolitik 58(5-6):42–47 Schmacke N (2004) Bewertung des Nutzens von Arzneimitteln aus ärztlicher Sicht. Gesundheits- und Sozialpolitik 58(5-6):42–47
Zurück zum Zitat Tunis SR, Stryer DB, Clancy CM (2003) Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12):1624–1632CrossRefPubMed Tunis SR, Stryer DB, Clancy CM (2003) Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12):1624–1632CrossRefPubMed
Zurück zum Zitat Weisz JR, Weiss B, Donenberg GR (1992) The lab versus the clinic: effects of child and adolescent psychotherapy. Am Psychol 47(12):1578–1585CrossRefPubMed Weisz JR, Weiss B, Donenberg GR (1992) The lab versus the clinic: effects of child and adolescent psychotherapy. Am Psychol 47(12):1578–1585CrossRefPubMed
Zurück zum Zitat Williams JI, Höher J, Lauterbach KW (1998) Health services research. In: Troidl H, McKneally MF, Mulder DS, Wechsler AS, McPeek B, Spitzer WO (eds) Surgical research—basic principles and clinical practice, 3rd edn. Springer, New York, pp 533–554 Williams JI, Höher J, Lauterbach KW (1998) Health services research. In: Troidl H, McKneally MF, Mulder DS, Wechsler AS, McPeek B, Spitzer WO (eds) Surgical research—basic principles and clinical practice, 3rd edn. Springer, New York, pp 533–554
Metadaten
Titel
Policy decision making and outcomes research in drug utilization
verfasst von
R. Rychlik
A. Wertheimer
H. Rusche
M. Augustin
S. Nelles
W. Böcking
Publikationsdatum
01.10.2005
Verlag
Springer-Verlag
Erschienen in
Journal of Public Health / Ausgabe 5/2005
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-005-0123-0

Weitere Artikel der Ausgabe 5/2005

Journal of Public Health 5/2005 Zur Ausgabe